Molecular epidemiology is the study of genetic and environmental risk for disease, with much effort centered on cancer. Childhood leukemia occurs in nearly a third of all patients newly diagnosed with pediatric cancer. only a small percentage of these new cases of childhood leukemia are associated with high penetrant hereditary cancer syndromes. Childhood leukemia, especially acute lymphoblastic leukemia, has been associated with a dysregulated immune system due to delayed infectious exposure at a young age. Identical twins with childhood leukemia suggest that acute lymphoblastic leukemia begins in utero and that the concordant presentation is due to a shared preleukemia subclone via placental transfer. Investigation of single nucleotide polymorphisms within candidate genes find that leukemia risk may be attributed to population-based polymorphisms affecting folate metabolism, xenobiotic metabolism, DNA repair, immunity, and B-cell development. More recently, genome-wide association studies for leukemia risk has led investigators to genes associated with B-cell development. When describing leukemia predisposition due to hereditary cancer syndromes, the following 6 categories become apparent on the basis of biology and clinical presentation: (1) genetic instability/DNA repair syndromes, (2) cell cycle/differentiation syndromes, (3) bone marrow failure syndromes, (4) telomere maintenance syndromes, (5) immunodeficiency syndromes, and (6) transcription factor syndromes and pure familial leukemia. understanding the molecular epidemiology of childhood leukemia can affect the treatment and tumor surveillance strategies for these high risk patients and their family members.
HartmanM, LoyEY, KuCS, . Molecular epidemiology and its current clinical use in cancer management. Lancet Oncol2010;11:383–90.
2.
PereraFP, WeinsteinIB. Molecular epidemiology: recent advances and future directions. Carcinogenesis2000;21:517–24.
3.
VineisP, PereraF. Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev2007;16:1954–65.
WiemelsJ. Perspectives on the causes of childhood leukemia. Chem Biol Interact2012;196:59–67.
6.
PuiCH, RellingMV, DowningJR. Acute lymphoblastic leukemia. N Engl J Med2004;350:1535–48.
7.
SeifAE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet2011;204:227–44.
8.
MullighanCG. The genomic landscape ofacute lymphoblastic leukemia in children and young adults. Hematology Am Soc Hematol Educ Program2014;2014:174–80.
9.
ChokkalingamAP, BufflerPA. Genetic susceptibility to childhood leukaemia. Radiat Prot Dosimetry2008;132:119–29.
10.
UrayamaKY, ChokkalingamAP, ManabeA, . Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia. Int J Hematol2013;97:3–19.
11.
SmithM, RiesL, GurneyJ, . Leukemia. In: RiesL, SmithM, GurneyJ, ., eds. Bethesda, MD: National Cancer Institute; 1999:17–35.
12.
LinaberyAM, RossJA. Trends in childhood cancer incidence in the U.S. (1992 2004). Cancer2008;112:416–32.
13.
KinlenL. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet1988;2:1323–27.
14.
KinlenLJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer1995;71:1–5.
15.
GreavesM. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer2006;6:193–203.
16.
GreavesMF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia1988;2:120–5.
17.
WiemelsJL, CazzanigaG, DaniottiM, . Prenatal origin of acute lymphoblastic leukaemia in children. Lancet1999;354:1499–503.
18.
GreavesMF, MaiaAT, WiemelsJL, . Leukemia in twins: lessons in natural history. Blood2003;102:2321–33.
19.
WangH, WangJ, ZhaoL, . Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies. BMC Med Genet2012;13:77.
20.
YanJ, YinM, DreyerZE, . A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer2012;58:513–8.
21.
GoyalRK, CooperJD. Meta-analyzing the link between MTHFR C677T genotype and susceptibility to childhood ALL. Pediatr Blood Cancer2012;58:483–4.
22.
ZintzarasE, DoxaniC, RodopoulouP, . Variants of the MTHFR gene and susceptibility to acute lymphoblastic leukemia in children: a synthesis of genetic association studies. Cancer Epidemiol2012;36:169–76.
23.
MetayerC, ScéloG, ChokkalingamAP, . Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control2011;22:1243–58.
24.
AzharMR, RahimiZ, Vaisi-RayganiA, . Lack of association between MTHFR C677T and A1298C polymorphisms and risk of childhood acute lymphoblastic leukemia in the Kurdish population from Western Iran. Genet Test Mol Biomarkers2012;16:198–202.
25.
NikbakhtM, MalekZadehK, Kumar JhaA, . Polymorphisms of MTHFR and MTR genes are not related to susceptibility to childhood ALL in North India. Exp Oncol2012;34:43–8.
26.
LupoPJ, NousomeD, KamdarKY, . A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control2012;23:1797–803.
27.
AmigouA, RudantJ, OrsiL, . Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control2012;23:1265–77.
28.
ZhuoW, ZhangL, QiuZ, . Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls. Gene2012;510:14–21.
29.
VijayakrishnanJ, HoulstonRS. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica2010;95:1405–14.
30.
ChokkalingamAP, MetayerC, SceloGA, . Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control2012;23:1367–75.
31.
ChanJY, UgrasenaDG, LumDW, . Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol2011;29:116–23.
32.
YeohAE, LuY, ChanJY, . Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. LeukRes2010;34:276–83.
33.
RimandoMG, ChuaMN, YusonE, . Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia). Biosci Rep2008;28:117–24.
34.
SuneethaKJ, NancyKN, RajalekshmyKR, . Role of GSTM1 (Present/Null) and GSTP1 (Ile105Val) polymorphisms in susceptibility to acute lymphoblastic leukemia among the South Indian population. Asian Pac J Cancer Prev2008;9:733–6.
35.
KrajinovicM, RicherC, SinnettH, . Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev2000;9:557–62.
36.
ZanrossoCW, EmerencianoM, FaroA, . Genetic variability in N-acetyltransferase 2 gene determines susceptibility to childhood lymphoid or myeloid leukemia in Brazil. Leuk Lymphoma2012;53:323–7.
37.
SilveiraVS, CanalleR, ScrideliCA, . CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Mol Cell Biochem2012;364(1-2):217–23.
38.
BonaventureA, Goujon-BellecS, RudantJ, . Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE). Cancer Causes Control2012;23:329–45.
39.
WangL, YinF, XuX, . X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis. PLoS One2012;7:e34897.
40.
WangR, HuX, ZhouY, . XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis. Leuk Lymphoma2013;54:153–9.
41.
DorakMT, OguzFS, YalmanN, . A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk Res2002;26:651–6.
42.
DorakMT, LawsonT, MachullaHK, . Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood1999;94:694–700.
43.
TaylorM, HussainA, UrayamaK, . The human major histocompatibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry. Blood Cells Mol Dis2009;42:129–35.
44.
EllinghausE, StanullaM, RichterG, . Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia2012;26:902–9.
45.
OrsiL, RudantJ, BonaventureA, . Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia2012;26:2561–4.
46.
PapaemmanuilE, HoskingFJ, VijayakrishnanJ, . Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet2009;41:1006–10.
47.
PrasadRB, HoskingFJ, VijayakrishnanJ, . Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood2010;115:1765–7.
48.
SherborneAL, HoskingFJ, PrasadRB, . Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet2010;42:492–4.
FletcherO, HoulstonRS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer2010;10:353–61.
51.
XuH, YangW, Perez-AndreuV, . Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst2013;105:733–42.
52.
WalshKM, de SmithAJ, ChokkalingamAP, . Novel childhood ALL susceptibility locus BMI1-PIP4K2A is specifically associated with the hyperdiploid subtype. Blood2013;121:4808–9.
53.
ChokkalingamAP, HsuLI, MetayerC, . Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control2013;24:1789–95.
54.
Perez-AndreuV, RobertsKG, XuH, . A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. Blood2015;125:680–6.
55.
Enciso-MoraV, HoskingFJ, SheridanE, . Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia2012;26:2212–5.
56.
LiFP, FraumeniJFJr. Soft-tissue sarcomas breast cancer other neoplasms. A familial syndrome?Ann Intern Med1969;71:747–52.
57.
MalkinD, LiFP, StrongLC, . Germ Line p53 mutations in a familial syndrome ofbreast cancer, sarcomas, and other neoplasms. Science1990;250:1233–8.
58.
LallooF, VarleyJ, EllisD, . Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet2003;361:1101–2.
59.
GonzalezKD, NoltnerKA, BuzinCH, . Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol2009;27:1250–6.
60.
PetitjeanA, MatheE, KatoS, . Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat2007;28:622–9.
61.
RuijsMW, VerhoefS, RookusMA, . TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet2010;47:421–8.
62.
KleihuesP, SchäubleB, zur HausenA, . Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol1997;150:1–3.
63.
HolmfeldtL, WeiL, Diaz-FloresE, . The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet2013;45:242–52.
64.
PowellBC, JiangL, MuznyDM, . Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing. Pediatr Blood Cancer2012;60:E1–E3.
65.
VillaniA, TaboriU, SchiiìmanJ, . Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol2011;12:559–67.
66.
KohlmannW, GruberSB. Lynch syndrome. In: PagonRA, RickTD, DolanCR., eds. GeneReviewsSeattle: University of Washington; 1993–2005.
67.
WimmerK, EtzlerJ. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?Hum Genet2008;124:105–22.
68.
FeltonKE, GilchristDM, AndrewSE. Constitutive deficiency in DNA mismatch repair. Clin Genet2007;71:483–98.
69.
ScottRH, MansourS, Pritchard-JonesK, . Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations. Nat Clin Pract Oncol2007;4:130–4.
70.
RippergerT, BegerC, RahnerN, . Constitutional mismatch repair deficiency and childhood leukemia/lymphoma report on a novel biallelic MSH6 mutation. Haematologica2010;95:841–4.
71.
BandipalliamP. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer2005;4:323–33.
72.
ChenS, WangW, LeeS, . Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA2006;296:1479–87.
73.
AlterBP, KupferG. Fanconi anemia. In: PagonRA, AdamMP, ArdingerHH, ., eds. GeneReviewsSeattle, WA: University of Washington; 1993–2005.
74.
SoulierJ, Fanconianemia. Hematology Am Soc Hematol Educ Program2011;2011:492–7.
75.
AlterBP. Cancer in Fanconi anemia, 1927-2001. Cancer2003;97:425–40.
76.
AlterBP, GreeneMH, VelazquezI, . Cancer in Fanconi anemia. Blood2003;101:2072.
77.
JonesKL, SmithDW. Smith 's Recognizable Patterns of Human Malformation6th ed. Philadelphia: Elsevier Saunders; 2006.
78.
GattiR. Ataxia-telangiectasia. In: PagonRA, AdamMP, ArdingerHH, ., eds. GeneReviewsSeattle, WA: University of Washington; 1993–2015.
79.
LiberzonE, AvigadS, StarkB, . Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children. Genes Chromosomes Cancer2004;39:161–6.
80.
VaronR, ReisA, HenzeG, . Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res2001;61:3570–2.
81.
KleierS, HerrmannM, WittwerB, . Clinical presentation and mutation identification in the NBS1 gene in a boy with Nijmegen breakage syndrome. Clin Genet2000;57:384–7.
82.
ConcannonP, GattiR, Nijmegen breakagesyndrome. In: PagonRA, BirdTD, DolanCR, ., eds. GeneReviewsSeattle Wash: University of Washington; 1993–2015.
83.
Nijmegen breakage syndrome. The International Nijmegen Breakage Syndrome Study Group. Arch Dis Child2000;82:400–6.
84.
PoppHD, BohlanderSK. Genetic instability in inherited and sporadic leukemias. Genes Chromosomes Cancer2010;49:1071–81.
85.
SanzMM, GermanJ, Bloom'ssyndrome. In: PagonRA, AdamMP, ArdingerHH, ., eds. GeneReviewsSeattle, WA: University of Washington; 1993–2015.
86.
GermanJ, SanzMM, CiocciS, . Syndrome-causing mutations of the BLM gene in persons in the Bloom's Syndrome Registry. Hum Mutat2007;28:743–53.
87.
GermanJ, Bloom's syndromeXX. The first 100 cancers. Cancer Genet Cytogenet1997;93:100–6.
88.
StieglitzE, LohML. Genetic predispositions to childhood leukemia. Ther Adv Hematol2013;4:270–90.
89.
MalkinD, NicholsKE, ZelleyK, . Predisposition to pediatric and hematologic cancers: a moving target. Am Soc Clin Oncol Educ Book2014:e44–e55.
90.
KnapkeS, ZelleyK, NicholsKE, . Identification, management, and evaluation of children with cancer-predisposition syndromes. Am Soc Clin Oncol Educ Book2012:576–84.
